Catalent
CTLT
#1737
Rank
C$15.91 B
Marketcap
C$87.70
Share price
0.00%
Change (1 day)
12.11%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: C$15.91 Billion

On February 19, 2025 Catalent had a market cap of C$15.91 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025C$15.91 B-3.73%
2024C$16.53 B53.6%
2023C$10.76 B-2.06%
2022C$10.99 B-62.37%
2021C$29.20 B33.64%
2020C$21.85 B103.02%
2019C$10.76 B74.05%
2018C$6.18 B-9.86%
2017C$6.86 B51.82%
2016C$4.51 B4.53%
2015C$4.32 B7.93%
2014C$4.00 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
C$3.61 B-77.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$1.04 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$14.24 B-10.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
C$1.09 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA